CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 120 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $46,000 | -73.6% | 7,400 | -50.0% | 0.00% | -100.0% |
| Q2 2019 | $174,000 | +21.7% | 14,800 | +64.4% | 0.00% | 0.0% |
| Q1 2019 | $143,000 | +62.5% | 9,000 | +21.6% | 0.00% | 0.0% |
| Q4 2018 | $88,000 | -38.5% | 7,400 | -17.8% | 0.00% | 0.0% |
| Q3 2018 | $143,000 | -7.1% | 9,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $154,000 | -21.8% | 9,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $197,000 | +55.1% | 9,000 | -6.2% | 0.00% | -50.0% |
| Q1 2016 | $127,000 | -39.2% | 9,600 | -13.5% | 0.00% | 0.0% |
| Q4 2015 | $209,000 | +2.0% | 11,100 | +1.8% | 0.00% | -33.3% |
| Q3 2015 | $205,000 | +31.4% | 10,900 | +3.8% | 0.00% | +50.0% |
| Q2 2015 | $156,000 | +9.9% | 10,500 | +11.7% | 0.00% | 0.0% |
| Q1 2015 | $142,000 | – | 9,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |